| Vytorin in Chronic Kidney Disease Gets FDA Committee Nod - Internal Medicine News Digital Network |
|
|
Internal Medicine News Digital Network Vytorin should be approved for preventing major vascular events in patients who have chronic kidney disease but are not on dialysis, according to a unanimous vote by an Food and Drug Administration advisory panel. However the panel also voted 10-6 that |